Dachaigh › Luchd-obrach › Olema Pharmaceuticals, Inc.
Olema Pharmaceuticals, Inc.: Tuarastalan H-1B agus taic bhìosa
Chuir Olema Pharmaceuticals, Inc. 7 iarrtasan cumha-obrach a-steach airson bhìosaichean H-1B agus bhìosaichean co-cheangailte ann am bliadhnaichean ionmhais 2023–2026; le teisteanas: 7. Tuarastal meadhanach a chaidh a thabhann: $200,000.
A bheil Olema Pharmaceuticals, Inc. a’ toirt taic do bhìosaichean H-1B?
Chuir Olema Pharmaceuticals, Inc. 7 iarrtasan cumha-obrach a-steach ann am bliadhnaichean ionmhais 2023–2026, an tè as ùire air a chur a-steach air 8 Gibl 2025. Is e LCA a’ chiad cheum ann an iarrtas H-1B, mar sin tha an neach-fastaidh air taic a thoirt do luchd-obrach H-1B no air ullachadh airson sin a dhèanamh; cha gharantaich e taic airson dreuchd shònraichte sam bith. Thoir sùil air liostaichean obrach an neach-fastaidh fhèin.
Tuarastalan a rèir tiotal obrach
| Tiotal dreuchd | LCAs | Tuarastal meadhanach |
|---|---|---|
| Senior Director Financial Planning and Accounting | 2 | $245,000 |
| Senior Manager, Regulatory Affairs Strategy | 1 | $183,000 |
| Principal Statistical Programmer | 1 | $190,000 |
| Manager, Clinical Trial Lead | 1 | $181,230 |
| Associate Director, Clinical Documentation and Trial Master | 1 | $200,000 |
| Senior Manager, Clinical Trial Lead | 1 | $218,500 |
Iarrtasan a rèir bliadhna ionmhais
| Bliadhna mhaoine | LCAs | Tuarastal meadhanach |
|---|---|---|
| FY2024 | 3 | $245,000 |
| FY2025 | 4 | $195,000 |
Ìrean tuarastail làithreach
Suidhichidh Roinn an Obrach ceithir ìrean tuarastail làithreach airson gach dreuchd agus sgìre, bho Ìre I (inntrigeadh) gu Ìre IV (gu tur comasach). Taghaidh an neach-fastaidh an ìre a fhreagras ri riatanasan na h-obrach.
Far a bheil na h-obraichean
Dreuchdan
- Accountants and Auditors2
- Natural Sciences Managers2
- Regulatory Affairs Specialists1
- Statisticians1
- Data Scientists1
Iarrtasan as ùire
| Tiotal dreuchd | Tuarastal bunasach | Àite | Air a chur a-steach | Ceann-latha tòiseachaidh | Inbhe |
|---|---|---|---|---|---|
| Senior Manager, Clinical Trial Lead | $218,500 Ìre II | San Francisco, CA | 8 Gibl 2025 | 28 Gibl 2025 | Dearbhaichte |
| Principal Statistical Programmer | $190,000 Ìre III | San Francisco, CA | 28 Gearr 2025 | 31 Màrt 2025 | Dearbhaichte |
| Manager, Clinical Trial Lead | $181,230 Ìre II | Cambridge, MA | 8 Faoi 2025 | 21 Faoi 2025 | Dearbhaichte |
| Associate Director, Clinical Documentation and Trial Master | $200,000 Ìre III | Cambridge, MA | 7 Faoi 2025 | 13 Faoi 2025 | Dearbhaichte |
| Senior Manager, Regulatory Affairs Strategy | $183,000 Ìre IV | San Francisco, CA | 20 Màrt 2024 | 1 Gibl 2024 | Dearbhaichte |
| Senior Director Financial Planning and Accounting | $245,000 Ìre III | Cambridge, MA | 29 Faoi 2024 | 10 Gearr 2024 | Dearbhaichte |
| Senior Director Financial Planning and Accounting | $245,000 Ìre III | Cambridge, MA | 16 Faoi 2024 | 25 Faoi 2024 | Dearbhaichte |
Is e na tuarastalan an ìre as ìsle den tuarastal a chaidh a thabhann air gach iarrtas, air an tionndadh gu suim bhliadhnail; cleachdaidh na staitistigean iarrtasan làn-aimsire le teisteanas a-mhàin. Chan eil LCA na aontachadh bhìosa agus faodaidh aon LCA còmhdach a dhèanamh air iomadh dreuchd. Stòr: Roinn an Obrach na SA, Dàta Foillseachaidh OFLC LCA, bliadhnaichean ionmhais 2023–2026 (co-dhùnadh as ùire 30 Ògmh 2026).